Max Delbruck


Also found in: Dictionary, Thesaurus, Medical.

Delbrück, Max

(1906–81) geneticist, virologist; born in Berlin, Germany. Trained as a physicist, he performed research in Europe, where he devised mathematical proofs for the chemical bonding of lithium and published two scientific papers on quantum mechanics. He began his fundamental investigations on bacteria and their viruses (bacteriophages) after coming to the U.S.A. to join the California Institute of Technology (Caltech) (1937–39). He continued his bacteriophage research through his years at Vanderbilt University (1940–47), where he showed that viruses can recombine genetic material (1946). Delbruk returned to Caltech (1947–76), where he later turned his interest to sensory physiology. With fellow bacteriophage researchers Salvador Luria and Alfred Hershey, he won the 1969 Nobel Prize in physiology for his contributions to viral genetics.

Delbrück, Max

 

Born Sept. 4, 1906, in Berlin. American physicist, geneticist, and virologist. Member of the US National Academy of Sciences.

A German by birth, Delbrück studied at the universities of Tubingen, Berlin, Bonn, and Göttingen from 1924 to 1930, receiving the degree of doctor of philosophy from the University of Göttingen. From 1932 to 1937 he worked at the Kaiser Wilhelm Institute. In 1937 he emigrated to the United States and worked at the California Institute of Technology (Pasadena, Calif.), where he became a professor of biology in 1947. His major works are devoted to nuclear physics, the analysis of spontaneous and induced mutations, bacteriophages, the physiology of the sense organs, and the quantum theory of the structure of chemical substances. For his work in the field of bacteriophages, Delbrück was awarded a Nobel Prize in 1969 (with A. Hershey and S. Luria).

WORKS

“Cosmic Rays and the Origin of Species.” Nature, 1936, vol. 137, p. 358. (With H. W. Timofeeff-Ressovsky.)
“On the Mechanism of DNA Replication.” (With G. S. Stent.) In the book Symposium on the Chemical Basis of Heredity. Edited by W. D. McElroy and B. Gloss. Baltimore, Md., 1957.
References in periodicals archive ?
Walter Birchmeier and Torben Redmer from the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch, a member of the Helmholtz Association, used mouse embryonic fibroblasts (MEFs) in their stem cell experiments.
Walther of the Max Delbruck Center for Molecular Medicine in Berlin-Buch and his colleagues created mutant mice that lack this enzyme.
Washington, May 28 (ANI): Researchers of the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch have discovered a specific molecule that enables embryonic stem cells to differentiate into diverse cell types and thus to be pluripotent.
Bohr's pupil Max Delbruck was most taken with this possibility, says Stent.
The Gerd Kempermann Lab, Max Delbruck Center for Molecular Medicine, Berlin
The Kidney Atlas was part of the European Renal Genome Project (EuReGene), coordinated by the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, which the European Union (EU) funded with more than 10 million euros.
The Jeff Macklis Lab, Massachusetts General Hospital, Harvard Medical School, Boston The Gerd Kempermann Lab, Max Delbruck Center for Molecular Medicine, Berlin The Jim Goldstein Lab, Columbia University The Arnold Krigstein Lab, University of California, San Francisco The Rob Wechsler-Reya Lab, Duke University, Durham, N.
This study helps to clarify the obstacles that antibodies face in blocking infection, and will hopefully shed more light on why developing an effective vaccine for HIV has proven so elusive," said Pamela Bjorkman, the Max Delbruck Professor of Biology at Caltech.
Ionix also announced that it had signed a pipeline deal with the Max Delbruck Centre for Molecular Medicine in Berlin-Buch Germany, providing exclusive rights to new discoveries made by the laboratory of Dr Gary Lewin in the field of analgesia.
The research team, consisting of experts from the Max Delbruck Centre for Molecular Medicine (MDC) Berlin-Buch and the Charite - Universitats Medizin Berlin (Germany), claim to have identified a gene called MACC1 (Metastasis-Associated in Colon Cancer 1).
a developer, manufacturer and marketer of DNA sequencing systems for applied genetic analysis, announced today the sale of a customized, high-throughput system to the Max Delbruck Center for Molecular Medicine (MDC) in Berlin, Germany.